Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | TriMark Publications | Clinical Laboratory Testing Volume 2 Business Strategies

Clinical Laboratory Testing Volume 2 Business Strategies

Clinical laboratory testing is generally categorized as either of two general areas--clinical testing and anatomical pathology testing. Clinical and anatomical pathology procedures are frequently ordered as part of regular physician office visits and hospital admissions in connection with the diagnosis and treatment of illnesses. As such, clinical laboratory analysis is one of the most important sections of medical care. The purpose of this TriMark Publications report is to describe the specific segments of the clinical laboratory analysis business. The emphasis in this review is on those companies that are actively developing and marketing laboratory data for the clinical setting, including hospitals, independent labs, physician's offices and miscellaneous clinics. This study concentrates on the clinical laboratory industry in the U.S. It defines the dollar volume of sales in each major market and analyzes the factors that influence the size and the growth of the individual market segments. The study surveys some of the primary companies known to be marketing clinical laboratory data into the market. Each company is discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market. The report attempts to answer the questions:

• What companies are the key players?

• What are the opportunities in clinical laboratory testing?

• What is happening with the information revolution?

• What are the development trends?

• Where are the new market growth areas?

This examination reviews the market for clinical laboratory data used in clinical practice. It defines the dollar volume of sales in each major market and analyzes the factors that influence the size and the growth of the individual market segments. The report details market sizes and growth rates for the U.S. and world markets. The study surveys some of the primary companies known to be marketing clinical laboratory data into the market. Each company is discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market. Unique benefits of this report are:

• In-depth analysis of the major sectors of the clinical laboratory business sector, their size, growth rates and major drivers.

• Presentation of some of the emerging business practices, elucidating the potential areas that could gain traction in this market.

• Analysis of the partnerships and alliances the various key sector players have forged, as well as describing financings of these market participants, giving insight into potential market collaborations.

• Examination of new business methods for clinical laboratories to identify lead positions and potential future growth areas.

• The reader will gain an understanding of key areas of the clinical laboratory testing business.

• New ways to adapt technology innovations and create new revenue streams.

• Sales and marketing strategies that will improve net income.

• Which diagnostic tests are emerging as high profit products.

• Transition to a consumer-based lab model.

• Financial underpinnings of entrepreneurial labs.

• Networking opportunities.

• Insights into the boomer emerging market and their growing expenditures on healthcare.

• Increased merger and acquisition (M&A) activity.

• Shift to preventative medicine.

• Point of care testing.

• Elements of personalized medicine, genetic testing and pharmacogenomics.

Publication Date: 01-APR-09

Pages: 98

Study: TMRCLTV2

Format/Price: PDF document / $1,999.00
Table of Contents
Price: $1,999.00 / €1,337.33

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions